SECsense Logo

Biogen Inc. 8-K Filing Report: Key Insights from June 17, 2025

$BIIB
Form 8-K
Filed on: 2025-06-23
Source
Biogen Inc. 8-K Filing Report: Key Insights from June 17, 2025

Here are the key insights extracted from the provided section of the financial report:

  1. Filing Details:
  • Form Type: 8-K
  • Filing Date: June 17, 2025
  1. Entity Information:
  • Company Name: Biogen Inc.
  • CIK (Central Index Key): 0000875045
  • SEC File Number: 0-19311
  • IRS Employer Identification Number (EIN): 33-0112644
  • Address: 225 Binney Street, Cambridge, MA 02142
  • Phone Number: 617-679-2000
  1. Stock Information:
  • Type of Securities: Common Stock
  • Par Value: $0.0005
  • Ticker Symbol: BIIB
  • Exchange: NASDAQ
  1. Reporting Period:
  • Start Date: June 17, 2025
  • End Date: June 17, 2025

Summary:

The financial report is an 8-K filing by Biogen Inc. dated June 17, 2025, detailing significant corporate events. The company operates under the ticker symbol BIIB on the NASDAQ exchange and has a common stock par value of $0.0005. The report includes important identifiers such as the CIK and SEC file number, and it is filed with the SEC for regulatory compliance. The document indicates a specific reporting period that is restricted to the same day, suggesting it may pertain to an event occurring on that date.